Video
Chris Kepinski, PharmD, sat down with Specialty Pharmacy Times at the National Community Oncology Dispensing Association conference in Denver, Colorado to discuss how treatment support kits act a vital resource for patients throughout their treatment.
Chris Kepinski, PharmD, sat down with Specialty Pharmacy Times at the National Community Oncology Dispensing Association (NCODA) conference in Denver, Colorado to discuss how treatment support kits act a vital resource for patients throughout their treatment.
Transcript
So the treatment support kits were created to basically give a ‘full kit’ for patients so that they will have everything they will need, whenever they would need it. The experience that we’ve really had with it is that there’s a lot of good knowledge and information in there as well as kind of, supportive care meds that work really well in the first few weeks. But we’re also seeing that some patients have side-effects a month or two down the road that they weren’t prepared for, but they have that kit ready, so it doesn’t give them any detrimental effects to their treatments. They can continue on, and they don’t have to dose change or anything like that. So we can really have a full treatment cycle through to see if the treatment is working for their disease at the time.
FDA Grants Orphan Drug Designation to MDL-101 for Congenital Muscular Dystrophy Type 1a